View source for Screening for atherosclerotic disease in other vascular beds in patient with lower extremity peripheral arterial disease

__NOTOC__

{{Peripheral arterial disease}}
{{CMG}} {{AE}} {{USAMA}}

=2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease<ref name="pmid27840333">{{cite journal| author=Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE et al.| title=2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | journal=Circulation | year= 2016 | volume=  | issue=  | pages=  | pmid=27840333 | doi=10.1161/CIR.0000000000000471 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27840333  }} </ref>=

==Recommendations for Screening for Atherosclerotic Disease in Other Vascular Beds for the Patient With PAD ==
===Recommendation for Abdominal Aortic Aneurysm([[AAA]]):===

{|class="wikitable" 
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
|-
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''A screening [[duplex ultrasound]] for abdominal aortic aneurysm ([[AAA]]) is reasonable in patients with symptomatic [[Peripheral arterial disease|PAD]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B-NR]])''<nowiki>"</nowiki>
|-
|}

===References===
{{Reflist|1}}